Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2008 Sep 16.
Published in final edited form as: J Am Chem Soc. 2005 Dec 7;127(48):16798–16799. doi: 10.1021/ja056287n

Cucurbit[10]uril

Simin Liu 1, Peter Y Zavalij 1, Lyle Isaacs 1,*
PMCID: PMC2538447  NIHMSID: NIHMS64015  PMID: 16316221

Abstract

Melamine diamine 1 is able to displace CB[5] from the CB[10]•CB[5] complex resulting in CB[10]•12 and precipitated CB[5]•1. We were able to isolate free CB[10] by treatment of CB[10]•1 with acetic anhydride followed by washing with MeOH, DMSO, and water. The spacious cavity of CB[10] is able to complex large guests including a cationic calix[4]arene derivative in its 1,3-alternate form (CB[10]•1,3-alt-3). The addition of adamantane carboxylic acid (4) to CB[10]•3 triggers a conformational change during the formation of termolecular complex CB[10]•cone-34.


In 1981, Mock disclosed the structure of cucurbit[6]uril (CB[6]) and subsequently delineated its outstanding binding properties toward ammonium ions in a series of elegant papers.1 Nearly 20 years later, the groups of Kim and Day reported the preparation and isolation of the CB[n] homologues CB[5], CB[7], CB[8] and CB[10] as its CB[10]•CB[5] inclusion complex.2 With their enhanced cavity size, the new members of the CB[n] family3 display a range of novel properties and applications including gas encapsulation, polarizability enhancement, and supramolecular dendrimer chemistry.4 Most notable, however, is the ability of CB[8] to simultaneously bind two aromatic guests which function as molecular machines in response to external stimuli.3b,5 In this paper we report the isolation of free CB[10] and disclose its unusual recognition properties. These results suggest that CB[10] will rival CB[8] for use as an advanced component for molecular machines and biomimetic systems.3,6

graphic file with name nihms64015f5.jpg

We isolated CB[10]•CB[5] in good quantities using a modification of the procedure reported by Day.2b,2c After much experimentation we discovered that treating a solution of CB[10]•CB[5] (Figure 1a) with a five equivalents of 1 results in the precipitation of the (CB[5]•1)n exclusion complex and the formation of the CB[10]•12 inclusion complex (Figure 1b). 1H NMR and x-ray crystallography indicates that 1 adopts a U-shape6 within the cavity of CB[10] (Figure 2); the two equivalents of 1 are arranged in a head-to-tail manner which results in a single set of resonances for Hb and Hc within CB[10]•12. The second equivalent of 1 is relatively weakly bound to CB[10] and can be removed by washing with MeOH to yield CB[10]•1 (Figure 1c). Once again, 1 adopts a U-shape within the CB[10]•1 complex; in this instance the top and bottom of CB[10] are differentiated and two sets of resonances are observed for Hb and Hc. Free CB[10] was obtained by heating CB[10]•1 in Ac2O followed by washing with (CH3)2SO, MeOH, and H2O (Figure 1d). CB[10] is quite stable in acidic solution (>1 month in 20% D2O/DCl at room temperature) which enabled our investigations of its molecular recognition properties.

Figure 1.

Figure 1

1H NMR spectra (400 MHz, D2O, 298 K) for: a) CB[10]•CB[5], b) CB[10]•12, c) CB[10]•1, d) CB[10] (20% D2O/DCl).

Figure 2.

Figure 2

Cross-eyed stereoview of the structure of CB[10]•12 in the crystal. Solvating water has been removed for clarity.

CB[10] is insoluble in D2O (< 50 µM) but its inclusion complexes often are nicely soluble which allows their characterization by NMR. Alternatively, CB[10] can be dissolved in 20% DCl / D2O for binding studies. An initial screen of many guests revealed that CB[10] – with its cavity volume of ≈ 870 Å3 – undergoes complexation with several chemically and biologically important substances (e.g. dyes, fluorophores, pharmaceuticals, and peptides) although some of these complexes occur as insoluble precipitates (Supporting Information). A soluble, kinetically stable complex was obtained with the more sizable and cationic guest (R)-2 which gave exclusively the termolecular complex CB[10]•(R)-22. Interestingly, when racemic (±)-2 was used, the racemic mixture of homochiral complexes (CB[10]•(R)-22 and CB[10]•(S)-22) was preferred relative to the heterochiral meso- complex (CB[10]•(R)-2•(S)-2) by a factor of three (Supporting Information). In combination, these results suggest that CB[10] may find application in drug delivery, for peptide sensing, and even to modulate the behavior of catalysts based on binaphthalene derived ligands.

Given the vast size of the CB[10] cavity we envisioned the encapsulation of smaller host molecules like cyclodextrins, calixarenes, or even CB[6] that would merge the advantageous features of these host families. In the event, only cationic calix[4]arene derivative 3 formed a soluble stable complex (CB[10]•3 Figure 3a). Based on the number and multiplicity of resonances observed for CB[10]•3, we conclude that 3 adopts a mixture of the D2d-symmetric 1,3-alternate conformation and a rapidly equilibrating mixture of cone, 1,2-alternate and partial cone conformers within the CB[10] host. Intrigued by the possibility of using allosteric effects to control the conformation of the macromolecular complex7 we studied the binding of small molecule guests to CB[10]•3. We found that substituted adamantanes (48) – which do not bind to 3 alone – induce a dramatic change in the conformer distribution during the formation of CB[10]•cone-3•adamantane complexes (Figure 3b).8 Scheme 1 shows an MMFF minimized model of the CB[10]•cone-34 complex.9 One of the hallmarks of biological allostery is the reversible response of the system to activator concentration. For this purpose we added stoichiometric amounts of CB[7] which sequesters 4 as its CB[7]•4 complex3b,6d and resets the system to its original CB[10]•3 state (Figure 3c).

Figure 3.

Figure 3

1H NMR spectra recorded (400 MHz, D2O / DCl, RT) for: a) CB[10]•3 (1,3-alt and dynamic equilibrium beween cone, 1,2-alt and partial cone), b) CB[10]•cone-34 with excess 4 (0.8 equiv.), and c) CB[10]•3 and CB[7]•4. Subscripts: 1,3 = 1,3-alt-3; dyn = dynamic equilibrium of 3.

Scheme 1.

Scheme 1

Allosteric control of the conformations of CB[10]•3 (MMFF minimized) with 4 (purple) and CB[7].

Just like the smaller CB[n] homologs, CB[10] retains the ability to bind a variety of chemically and biologically important cationic substances within its cavity. We have further demonstrated that CB[10] readily forms termolecular complexes (e.g. CB[10]•22 and CB[10]•cone-34); the vast cavity volume of CB[10] (≈ 870 Å3) suggests the potential formation of even higher molecularity complexes. The termolecular complexes already display a range of intriguing behavior including chiral recognition and efficient allosteric control of macromolecular geometry in response to a small molecule (e.g. 4). Overall, these results suggest that CB[10] will find broad application as an advanced component of molecular machines and biomimetic systems.

Supplementary Material

1si20050923_03. Supporting Information Available.

Synthetic procedures, characterization data for CB[10], and selected 1H NMR spectra for CB[10]•guest complexes (.pdf), and details of the x-ray structure of CB[10]•12 (.cif). This material is available free of charge via the internet at http://pubs.acs.org.

2si20051022_09

Acknowledgement

We thank the National Institutes of Health (GM61854) and the University of Maryland for financial support.

References

  • 1.(a) Freeman WA, Mock WL, Shih N-Y. J. Am. Chem. Soc. 1981;103:7367–7368. [Google Scholar]; (b) Mock WL. Top. Curr. Chem. 1995;175:1–24. [Google Scholar]
  • 2.(a) Kim J, Jung IS, Kim S-Y, Lee E, Kang J-K, Sakamoto S, Yamaguchi K, Kim K. J. Am. Chem. Soc. 2000;122:540–541. [Google Scholar]; (b) Day AI, Arnold AP, Blanch RJ, Snushall B. J. Org. Chem. 2001;66:8094–8100. doi: 10.1021/jo015897c. [DOI] [PubMed] [Google Scholar]; (c) Day AI, Blanch RJ, Arnold AP, Lorenzo S, Lewis GR, Dance I. Angew. Chem. Int. Ed. 2002;41:275–277. doi: 10.1002/1521-3773(20020118)41:2<275::aid-anie275>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  • 3.(a) Lagona J, Mukhopadhyay P, Chakrabarti S, Isaacs L. Angew. Chem. Int. Ed. 2005;44:4844–4870. doi: 10.1002/anie.200460675. [DOI] [PubMed] [Google Scholar]; (b) Lee JW, Samal S, Selvapalam N, Kim H-J, Kim K. Acc. Chem. Res. 2003;36:621–630. doi: 10.1021/ar020254k. [DOI] [PubMed] [Google Scholar]
  • 4.(a) Miyahara Y, Abe K, Inazu T. Angew. Chem. Int. Ed. 2002;41:3020–3023. doi: 10.1002/1521-3773(20020816)41:16<3020::AID-ANIE3020>3.0.CO;2-4. [DOI] [PubMed] [Google Scholar]; (b) Kellersberger KA, Anderson JD, Ward SM, Krakowiak KE, Dearden DV. J. Am. Chem. Soc. 2001;123:11316–11317. doi: 10.1021/ja017031u. [DOI] [PubMed] [Google Scholar]; (c) Marquez C, Nau WM. Angew. Chem. Int. Ed. 2001;40:4387–4390. doi: 10.1002/1521-3773(20011203)40:23<4387::aid-anie4387>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]; (d) Moon K, Grindstaff J, Sobransingh D, Kaifer AE. Angew. Chem. Int. Ed. 2004;43:5496–5499. doi: 10.1002/anie.200460179. [DOI] [PubMed] [Google Scholar]
  • 5.(a) Jeon WS, Kim E, Ko YH, Hwang I, Lee JW, Kim S-Y, Kim HJ, Kim K. Angew. Chem. Int. Ed. 2005;44:87–91. doi: 10.1002/anie.200461806. [DOI] [PubMed] [Google Scholar]; (b) Ko YH, Kim K, Kang J-K, Chun H, Lee JW, Sakamoto S, Yamaguchi K, Fettinger JC, Kim K. J. Am. Chem. Soc. 2004;126:1932–1933. doi: 10.1021/ja031567t. [DOI] [PubMed] [Google Scholar]; (c) Jeon WS, Ziganshina AY, Lee JW, Ko YH, Kang JK, Lee C, Kim K. Angew. Chem. Int. Ed. 2003;42:4097–4100. doi: 10.1002/anie.200351925. [DOI] [PubMed] [Google Scholar]; (d) Jeon YJ, Bharadwaj PK, Choi SW, Lee JW, Kim K. Angew. Chem. Int. Ed. 2002;41:4474–4476. doi: 10.1002/1521-3773(20021202)41:23<4474::AID-ANIE4474>3.0.CO;2-S. [DOI] [PubMed] [Google Scholar]
  • 6.(a) Lee H-K, Park KM, Jeon YJ, Kim D, Oh DH, Kim HS, Park CK, Kim K. J. Am. Chem. Soc. 2005;127:5006–5007. doi: 10.1021/ja042172s. [DOI] [PubMed] [Google Scholar]; (b) Jeon YJ, Kim H, Jon S, Selvapalam N, Oh DH, Seo I, Park C-S, Jung SR, Koh D-S, Kim K. J. Am. Chem. Soc. 2004;126:15944–15945. doi: 10.1021/ja044748j. [DOI] [PubMed] [Google Scholar]; (c) Braha O, Webb J, Gu L-Q, Kim K, Bayley H. ChemPhysChem. 2005;6:889–892. doi: 10.1002/cphc.200400595. [DOI] [PubMed] [Google Scholar]; (d) Liu S, Ruspic C, Mukhopadhyay P, Chakrabarti S, Zavalij PY, Isaacs L. J. Am. Chem. Soc. 2005;127 doi: 10.1021/ja055013x. ASAP. [DOI] [PubMed] [Google Scholar]
  • 7.Castellano RK, Rudkevich DM, Rebek J., Jr J. Am. Chem. Soc. 1996;118:10002–10003. [Google Scholar]
  • 8.Addition of 1 equiv. 4 to a solution of CB[10]•3 (500 µM) results in ≊ 90% formation of CB[10] • cone-34 reflecting the strong binding of 4 to CB[10] •3. A larger number of equivalents of 58 are required to complete the conformation change presumably because of weaker binding interactions of tetracationic CB[10] •3 with these cationic guests.
  • 9.The 1H NMR spectrum of CB[10]•cone-34 does not show doubling of the Hg and Hj resonances as expected for the geometry shown in Scheme 1. We attribute this result to a dynamic process in which 4 reorients its CO2H group between the two portals rapidly on the chemical shift timescale. The bulkier adamantanes 7 and 8 display two sets of resonances as expected.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1si20050923_03. Supporting Information Available.

Synthetic procedures, characterization data for CB[10], and selected 1H NMR spectra for CB[10]•guest complexes (.pdf), and details of the x-ray structure of CB[10]•12 (.cif). This material is available free of charge via the internet at http://pubs.acs.org.

2si20051022_09

RESOURCES